Phase 3, non-randomized, Multicenter, single arm study to assess efficacy and safety of Abnoba viscum F 20mg in patients with malignant pleural effusion
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
68
intravesical instillation of five amples of AbnobaViscum® F20mg and 0.9% normal saline into the pleural space
Busan University Hospital
Busan, Busan, South Korea
Chonnam National University Hwasun hospital
Hwasun Gun, Jeollanam-do, South Korea
Ulsan University Hospital
Ulsan, Ulsan, South Korea
Efficacy
Efficacy assessment of pleural effusion with Chest X-ray after 4 weeks of final treatment
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.